- Home
- ARVN vs ITRG Comparison
ARVN vs ITRG Comparison
Compare ARVN & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | ITRG |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 874.5M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ARVN | ITRG |
|---|---|---|
| Price | $12.48 | $3.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 2 |
| Target Price | ★ $15.71 | $5.13 |
| AVG Volume (30 Days) | 722.4K | ★ 1.9M |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | $733.38 |
| Revenue Next Year | N/A | $46.00 |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.90 | $1.05 |
| 52 Week High | $14.22 | $4.87 |
Technical Indicators
Market Signals| Indicator | ARVN | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 38.97 |
| Support Level | $11.07 | $3.27 |
| Resistance Level | $12.62 | $4.56 |
| Average True Range (ATR) | 0.79 | 0.22 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 47.81 | 3.00 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.